EIR Livzon Group Fuzhou Fuxing Pharmaceutical Mar 2015

Constantin Philopoulos FDA$595.00 - Available Now

FDA investigators audited the Livzon Group Fuzhou Fuxing Pharmaceutical - Fuzhou, China facility and issued inspectional observation (via FDA 483) on 20 Mar 2015.

Product details

  • Category:
  • Inspection end: 20 Mar 2015
  • Location: Fuzhou, China
  • FEI: 3006772356
Add To Cart